Ignite Creation Date:
2025-12-25 @ 1:32 AM
Ignite Modification Date:
2025-12-25 @ 11:46 PM
Study NCT ID:
NCT01934894
Status:
TERMINATED
Last Update Posted:
2017-07-02
First Post:
2013-08-27
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Cabazitaxel Plus Lapatinib as Therapy for HER2-Positive Metastatic Breast Cancer Patients With Intracranial Metastases
Sponsor:
SCRI Development Innovations, LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-05
Start Date Type:
ACTUAL
Primary Completion Date:
2016-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-04
Completion Date Type:
ACTUAL
First Submit Date:
2013-08-27
First Submit QC Date:
None
Study First Post Date:
2013-09-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-02-01
Results First Submit QC Date:
None
Results First Post Date:
2017-06-02
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-06-01
Last Update Post Date:
2017-07-02
Last Update Post Date Type:
ACTUAL